 |
|
Neuroleptic-Induced Extrapyramidal Symptoms With FeverHeterogeneity of the 'Neuroleptic Malignant Syndrome'
Douglas F. Levinson, MD;
George M. Simpson, MD
Arch Gen Psychiatry. 1986;43(9):839-848.
Abstract
• From 39 reported cases of the "neuroleptic malignant syndrome," three groups were identified: those with concurrent medical problems that could cause fever that accompanied the extrapyramidal symptoms; those with medical problems less clearly related to fever; and those without other medical disorders. Dehydration, infection, pulmonary embolus, and rhabdomyolysis were the common complications of untreated extrapyramidal symptoms. Three patients died, all with medical complications. In 14 cases, no medical cause of fever was identified. Hypotheses about mechanisms for fever include psychiatric illness, disruption of dopaminergic aspects of thermoregulation, and peripheral and central effects on muscle contraction leading to excess heat production. Neuroleptic-induced rigidity should be treated vigorously, with prompt discontinuation of neuroleptic therapy and administration of dopamine agonists in severe cases with or without fever. The cases of extrapyramidal symptoms with fever are too heterogeneous to justify the assumption of a unitary and "malignant" syndrome.
Author Affiliations
From the Department of Psychiatry, Medical College of Pennsylvania at Eastern Pennsylvania Psychiatric Institute, Philadelphia.
Footnotes
Accepted for publication June 4, 1985.
Reprint requests to 3200 Henry Ave, Philadelphia, PA 19129 (Dr Levinson).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
'Withdrawal neuroleptic malignant syndrome': a phantom explanatory cause for a fatality
Gillman
Med Sci Law 2011;51:122-123.
FULL TEXT
Multiple Triggers for NMS
Gillman
Australas Psychiatry 2010;18:266-266.
FULL TEXT
Hyperthermia syndromes in psychiatry
Ahuja and Cole
Adv. Psychiatr. Treat. 2009;15:181-191.
ABSTRACT
| FULL TEXT
Grand rounds: catatonia
Carey et al.
The Psychiatrist 2002;26:68-70.
FULL TEXT
Neuroleptic Toxicity Syndromes: A Clinical Spectrum
Reilly et al.
Aust N Z J Psychiatry 1991;25:499-505.
ABSTRACT
Risk Factors for Neuroleptic Malignant Syndrome: A Case-Control Study
Keck et al.
Arch Gen Psychiatry 1989;46:914-918.
ABSTRACT
Neuroleptic Malignant Syndrome
Caroff et al.
Arch Gen Psychiatry 1987;44:838-839.
ABSTRACT
Review Article: Psychopharmacologic Treatment in Neurological Practice
Dubovsky and Ringel
Neurorehabil Neural Repair 1987;1:51-66.
|
